Zymeworks (ZYME) Amortizatization of Intangibles (2021 - 2026)

Zymeworks' (ZYME) quarterly Amortizatization of Intangibles came in at $176000.0 in Q1 2026, down 75.11% year-on-year from $707000.0 in Q1 2025, and down 80.95% quarter-over-quarter from $924000.0 in Q4 2025.

Zymeworks (ZYME) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends

Zymeworks has disclosed Amortizatization of Intangibles across 6 years of filings, most recently posting $176000.0 for Q1 2026.

  • Amortizatization of Intangibles for Q1 2026 came in at $176000.0, down 75.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.9 million (down 36.59% YoY), and the FY2025 annual result was $3.4 million, down 24.71% from the prior year.
  • Amortizatization of Intangibles came in at $176000.0 for Q1 2026 at Zymeworks, down from $924000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $2.9 million in Q1 2022 to a low of $176000.0 in Q1 2026.
  • The 5-year median for Amortizatization of Intangibles is $707000.0 (2025), against an average of $913411.8.
  • Across the five-year window, Amortizatization of Intangibles surged 231.75% in 2022 and tumbled 77.77% in 2023, its largest moves.
  • Zymeworks' Amortizatization of Intangibles stood at $627000.0 in 2022, then increased by 7.34% to $673000.0 in 2023, then surged by 197.47% to $2.0 million in 2024, then tumbled by 53.85% to $924000.0 in 2025, then sank by 80.95% to $176000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $176000.0 (Q1 2026), $924000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Zymeworks 1.73 Bn 1.36 Bn - 176,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 176,000.00
Mar 31, 2026 176,000.00
Dec 31, 2025 924,000.00
Dec 31, 2025 924,000.00
Sep 30, 2025 1.03 Mn
Sep 30, 2025 1.03 Mn
Jun 30, 2025 723,000.00
Jun 30, 2025 723,000.00
Mar 31, 2025 707,000.00
Mar 31, 2025 707,000.00
Dec 31, 2024 2.00 Mn
Dec 31, 2024 2.00 Mn
Sep 30, 2024 980,000.00
Sep 30, 2024 980,000.00
Jun 30, 2024 812,000.00
Jun 30, 2024 812,000.00
Mar 31, 2024 702,000.00
Mar 31, 2024 702,000.00
Dec 31, 2023 673,000.00
Dec 31, 2023 673,000.00